Solara Active Pharma Sciences628.25
+0.00 (-1.93%)

Solara Active Pharma Sciences Share Price

628.25+0.00 (-1.93%)
+14.71% past 1 Year

Corporate filings & documents

Announcements

Solara Active Pharma Sciences Limited has informed the Exchange about copy of Newspaper Advertisement published with respect to dispatch of the Notice of Postal Ballot dated November 17 2026
4 days ago
Solara Active Pharma Sciences has informed the exchange regarding Notice of Postal Ballot dated November 17 2026
4 days ago
Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30 2026
4 weeks ago
Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30 2026
4 weeks ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the copy of Newspaper publication informing about Final Reminder-cum-Forfeiture Notice for the payment of First call and/or Second and final call to the holders of partly paid-up Equity shares.
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the copy of Newspaper publication informing about Final Reminder-cum-Forfeiture Notice for the payment of First call and/or Second and final call to the holders of partly paid-up Equity shares.
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders of Partly paid-up equity shares of the Company
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders of Partly paid-up equity shares of the Company
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the copy of the Newspaper publication providing extract of the unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30 2026
1 month ago
Monitoring Agency Report for the quarter ended September 30 2026
1 month ago
Monitoring Agency Report for the quarter ended September 30 2026
1 month ago
Audio recordings of Q2 FY27 earnings call conducted on October 16 2026 for the quarter ended September 30 2026
1 month ago
Audio recordings of Q2 FY27 earnings call conducted on October 16 2026 for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16 2026 titled "Solaras Q2 FY 27 revenue grows 33% to INR 4 178 Mn and EBITDA more than doubles to INR 769 Mn its best quarter in five years"
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16 2026 titled "Solaras Q2 FY 27 revenue grows 33% to INR 4 178 Mn and EBITDA more than doubles to INR 769 Mn its best quarter in five years"
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8 300 Equity shares pursuant to exercise of ESOP options.
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8 300 Equity shares pursuant to exercise of ESOP options.
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended September 30 2026 along with the Limited Review Report for the said period.
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended September 30 2026 along with the Limited Review Report for the said period.
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026 along with the Limited Review Report for the said period.
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026 along with the Limited Review Report for the said period.
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday October 16 2026 at 4.00 PM IST to discuss the Companys unaudited financial results for the quarter and half year ended September 30 2026.
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday October 16 2026 at 4.00 PM IST to discuss the Companys unaudited financial results for the quarter and half year ended September 30 2026.
1 month ago
Solara Active Pharma has informed the Exchange regarding the ESG Rating received from Crisil ESG Rating & Analytics Limited
1 month ago
Solara Active Pharma has informed the Exchange regarding the ESG Rating received from Crisil ESG Rating & Analytics Limited
1 month ago
Update on approval of Final Reminder cum Forfeiture Notice for payment of outstanding call money.
1 month ago
Update on approval of Final Reminder cum Forfeiture Notice for payment of outstanding call money.
1 month ago
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2026 inter alia to consider and approve unaudited financial results of the Company for the quarter and half year ended September 30 2026
1 month ago
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2026 inter alia to consider and approve unaudited financial results of the Company for the quarter and half year ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2026
1 month ago
Intimation to furnish valid PAN. KYC details and Nomination by shareholders holding physical Shares
1 month ago
Intimation regarding Closure of Trading window for the quarter ended September 30 2026
1 month ago
Intimation regarding Closure of Trading window for the quarter ended September 30 2026
1 month ago
Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizers report of the Ninth Annual General Meeting
2 months ago
Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizers report of the Ninth Annual General Meeting
2 months ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18 2026.
2 months ago
Solara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18 2026.
2 months ago
Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
2 months ago
Solara Active Pharma Sciences Limited has informed the exchange about intimation in connection with the receipt of Rectification Order
2 months ago
Newspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
2 months ago
Newspaper publication regarding the completion of dispatch of 9th AGM Notice and Annual report
2 months ago
Business Responsibility and Sustainability Reporting for the financial year 2025-26.
2 months ago
Business Responsibility and Sustainability Reporting for the financial year 2025-26.
2 months ago
Annual Report for the financial year ended March 31 2026
2 months ago

Concalls & investor presentations

Oct 2026
ConcallPresentation
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation

Solara Active Pharma Sciences Ltd Share Price Today

The Solara Active Pharma Sciences Ltd share price today is ₹716.7. During the trading session, the Solara Active Pharma Sciences Ltd share price opened at ₹726 and recorded an intraday high of ₹736.95 and a low of ₹698. Last closing price was ₹725.4. Over the past 52 weeks, the Solara Active Pharma Sciences Ltd share price has ranged between ₹422 and ₹774. The current Solara Active Pharma Sciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.